Sly Saint
Senior Member (Voting Rights)
"Hemispherx to Present at the 30th Annual ROTH Conference
ORLANDO, Fla., March 05, 2018 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc.(NYSE American:HEB), focused on pharmaceutical research, announced today that it will be presenting at the 30th Annual ROTH Conference on Monday, March 12th at 5:30PM PT in Green - Salon 3 (the time may be subject to changes depending on the conference organizers) at the Ritz Carlton in Dana Point, California.
The Company webcast can be found at http://wsw.com/webcast/roth32/heb/ following the presentation on March 12th.
Thomas K. Equels, M.S. J.D., Chief Executive Officer of Hemispherx Biopharma, will be presenting as well as meeting with investors one-on-one.
Mr. Equels' presentation will focus on ME/CFS (Myalgic Encephalomyelitis/Chronic Fatigue Syndrome), immuno-oncology, and immune system amplification for enhanced viral vaccines."
https://www.nasdaq.com/press-releas...he-30th-annual-roth-conference-20180305-00595
ORLANDO, Fla., March 05, 2018 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc.(NYSE American:HEB), focused on pharmaceutical research, announced today that it will be presenting at the 30th Annual ROTH Conference on Monday, March 12th at 5:30PM PT in Green - Salon 3 (the time may be subject to changes depending on the conference organizers) at the Ritz Carlton in Dana Point, California.
The Company webcast can be found at http://wsw.com/webcast/roth32/heb/ following the presentation on March 12th.
Thomas K. Equels, M.S. J.D., Chief Executive Officer of Hemispherx Biopharma, will be presenting as well as meeting with investors one-on-one.
Mr. Equels' presentation will focus on ME/CFS (Myalgic Encephalomyelitis/Chronic Fatigue Syndrome), immuno-oncology, and immune system amplification for enhanced viral vaccines."
https://www.nasdaq.com/press-releas...he-30th-annual-roth-conference-20180305-00595